<code id='1092BE71F4'></code><style id='1092BE71F4'></style>
    • <acronym id='1092BE71F4'></acronym>
      <center id='1092BE71F4'><center id='1092BE71F4'><tfoot id='1092BE71F4'></tfoot></center><abbr id='1092BE71F4'><dir id='1092BE71F4'><tfoot id='1092BE71F4'></tfoot><noframes id='1092BE71F4'>

    • <optgroup id='1092BE71F4'><strike id='1092BE71F4'><sup id='1092BE71F4'></sup></strike><code id='1092BE71F4'></code></optgroup>
        1. <b id='1092BE71F4'><label id='1092BE71F4'><select id='1092BE71F4'><dt id='1092BE71F4'><span id='1092BE71F4'></span></dt></select></label></b><u id='1092BE71F4'></u>
          <i id='1092BE71F4'><strike id='1092BE71F4'><tt id='1092BE71F4'><pre id='1092BE71F4'></pre></tt></strike></i>

          explore

          explore

          author:entertainment    Page View:896
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Readout Newsletter: The latest on Amylyx, Moderna, Novavax
          Readout Newsletter: The latest on Amylyx, Moderna, Novavax

          JUSTINTALLIS/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup toge

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          5 ways to address the shortage of health care workers

          Haltingandreversingthegrowingshortageofhealthcareworkerswillrequirecreativesolutionsandpartnerships.